This slideshow reviews azacitidine (Vidaza), Indicated for the treatment of French-American-British (FAB) myelodysplastic syndrome subtypes.
This slideshow examines bendamustine (Treanda), indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).
This slideshow reviews afatinib (Gilotrif) for the treatment of non-small cell lung cancer (NSCLC).
This slideshow reviews Pertuxumab (Perjeta) for the treatment of HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin) and docetaxel ...
This slideshow reviews Tamoxifen for the treatment of metastatic breast cancer in women and men
This slideshow reviews Glucarpidase (Voraxaze) for the treatment of toxic plasma methotrexate concentrations (>1 μmol/L) in patients with delayed methotrexate ...
This slideshow reviews Axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of prior systemic therapy.
This slideshow reviews Vismodegib (Erivedge) for the treatment of metastatic basal cell carcinoma.
Azacitidine is a DNA methylation inhibitor indicated for the treatment of several FAB myelodysplastic syndrome subtypes.
Pazopanib is a tyrosine kinase inhibitor indicated for renal cell carcinoma and advanced soft tissue sarcoma in patients who have received prior chemotherapy.
Vincristine is a vinca alkaloid indicated for the treatment of certain cancers, and may also be used in some combination therapies.
Vemurafenib is a B-RAF enzyme inhibitor indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation.
Cabazitaxel is a taxane derivative indicated to treat hormone-refractory metastatic prostate cancer in patients previously treated with docetaxel.
Asparaginase Erwinia chrysanthemi is a component of a multiagent regimen for treatment of acute lymphoblastic leukemia.
An antibody-drug conjugate indicated for the treatment of Hodgkin lymphoma and sALCL after failure of prior multiagent regimens.
Methylnaltrexone is a peripheral acting narcotic antagonist, opioid reversing agent. It is indicated for treatment of opioid-induced constipation.
Ipilimumab is a recombinant, human cytotoxic T-lymphocyte antigen 4-blocking monoclonal antibody indicated for the treatment of unresectable or metastatic melanoma.
Oxaliplatin is a platinum-containing antineoplastic agent used to treat lymph node positive colorectal carcinoma and metastatic colorectal cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|